Abbott Wins Nod for 14 Day Version of Freestyle Libre

Abbott Laboratories has received FDA approval of the Freestyle Libre 14 Day Flash Glucose Monitoring System (CGM). FDA’s nod of the Abbott, IL-based company’s device follows on the heels of the 2017 approval of the 10 Day Freestyle Libre CGM in the U.S.